|
RAD54B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64035451888367E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73959999960616E-07 |
| Normal-vs-Stage2 |
1.675340E-03 |
| Normal-vs-Stage3 |
5.85290005350458E-09 |
| Normal-vs-Stage4 |
5.85549999598811E-08 |
| Stage1-vs-Stage2 |
8.123700E-02 |
| Stage1-vs-Stage3 |
1.732060E-02 |
| Stage1-vs-Stage4 |
3.923700E-03 |
| Stage2-vs-Stage3 |
4.342400E-01 |
| Stage2-vs-Stage4 |
9.183400E-01 |
| Stage3-vs-Stage4 |
2.524200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95399252334028E-13 |
| Normal-vs-AfricanAmerican |
9.626100E-04 |
| Normal-vs-Asian |
2.839600E-02 |
| Caucasian-vs-AfricanAmerican |
1.990050E-01 |
| Caucasian-vs-Asian |
1.205680E-02 |
| AfricanAmerican-vs-Asian |
8.135900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33226762955019E-15 |
| Normal-vs-Female |
6.13459999999622E-05 |
| Male-vs-Female |
1.264340E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.638800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.74129599628259E-11 |
| Normal-vs-Age(61-80Yrs) |
1.14989999744353E-08 |
| Normal-vs-Age(81-100Yrs) |
6.398200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.758800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.776400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.176000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.892800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.448000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.552600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.453610E-01 |
| Normal-vs-Grade 2 |
2.71250000238865E-08 |
| Normal-vs-Grade 3 |
2.91559998366608E-09 |
| Normal-vs-Grade 4 |
4.1647999493577E-09 |
| Grade 1-vs-Grade 2 |
1.112780E-01 |
| Grade 1-vs-Grade 3 |
1.237550E-02 |
| Grade 1-vs-Grade 4 |
1.919480E-03 |
| Grade 2-vs-Grade 3 |
8.323600E-02 |
| Grade 2-vs-Grade 4 |
5.218600E-03 |
| Grade 3-vs-Grade 4 |
2.832800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64185999999011E-05 |
| Normal-vs-ccB subtype |
4.89460028063604E-10 |
| ccA subtype-vs-ccB subtype |
3.186100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.80539965994365E-10 |
| Normal-vs-N1 |
3.263200E-03 |
| N0-vs-N1 |
2.171600E-01 |
|
|
